A review of antidepressant-induced urinary hesitancy: a focus on levomilnacipran ER including two case presentations(5633).

about

A review of antidepressant-induced urinary hesitancy: a focus on levomilnacipran ER including two case presentations(5633).

Item

http://www.wikidata.org/entity/Q38770060

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A review of antidepressant-ind ...... two case presentations(5633).

@en

type

Item

label

A review of antidepressant-ind ...... two case presentations(5633).

@en

prefLabel

A review of antidepressant-ind ...... two case presentations(5633).

@en

P1476

A review of antidepressant-ind ...... two case presentations(5633).

@en

P2093

Elishka Caneva

http://www.w3.org/2001/XMLSchema#string

Gregory M Asnis

http://www.w3.org/2001/XMLSchema#string

Margaret A Henderson

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder

A rating scale for depression

Levomilnacipran for the treatment of major depressive disorder: a review

A new depression scale designed to be sensitive to change

Guideline for the primary care management of male lower urinary tract symptoms.

Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant--what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind, placebo-controlled study

The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews.

P304

717-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2016.1164138

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26967743

http://www.w3.org/2001/XMLSchema#string